IceCure Medical (ICCM) Operating Margin (2025 - 2026)

IceCure Medical (ICCM) reported Operating Margin of 466.19% for Q1 2026, down 3822.0% year-over-year from 12.53% in Q1 2025, and down 7.58% on a QoQ basis from 504.41% in Q1 2025.

IceCure Medical (ICCM) has 2 years of Operating Margin data on file, last reported at 466.19% in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.05%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 15.55%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 16.24%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.17%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.04%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.94%
10 IceCure Medical 12.09 -8.11 Mn 295,000.00 466.19%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 466.19%
Mar 31, 2025 504.41%